Increasing pharmaceutical production in Poland is necessary in the current geopolitical situation to ensure access to essential medicines. Representatives of the Military Health Service, the Ministry of Health and the National Drug Manufacturers are unanimous in pointing out that individual ministries cannot effectively accomplish this task on their own. The involvement of the NPRM is needed.
During a meeting of the Senate Committee on National Defense on April 8 on the functioning of the pharmaceutical industry in emergencies and war, invited guests stressed that only inter-ministerial action can lead to an increase in pharmaceutical production in Poland.
- Legislative support for the pharmaceutical sector and financial incentives to increase production of critical medicines are a key element in the context of strategic health, defense and economic challenges, noted Krzysztof Kopeć, president of National Drug Manufacturers.
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.
If you already have an account, please log in
